WalterNKernanMD
Internal Medicine • New Haven, CTProfessor, Internal Medicine, Yale University School of Medicine. Preventative Cardiology
Dr. Kernan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
789 Howard Ave
New Haven, CT 06519Phone+1 203-688-2471Fax+1 203-688-4516
Education & Training
Johns Hopkins UniversityResidency, Internal Medicine, 1984 - 1987
Geisel School of Medicine at DartmouthClass of 1984
Certifications & Licensure
CT State Medical License 1987 - 2025
FL State Medical License 2012 - 2018- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Insulin Resistance Intervention After Stroke Trial Start of enrollment: 2005 Feb 01
Publications & Presentations
PubMed
- 97 citationsPioglitazone after Ischemic Stroke or Transient Ischemic Attack.Walter N Kernan, Catherine M Viscoli, Karen L Furie, Lawrence H Young, Silvio E Inzucchi
The New England Journal of Medicine. 2016-04-07 - 80 citationsPioglitazone and Risk for Bone Fracture: Safety Data From a Randomized Clinical Trial.Catherine M. Viscoli, Silvio E. Inzucchi, Lawrence H. Young, Karl L. Insogna, Robin Conwit
The Journal of Clinical Endocrinology and Metabolism. 2016-12-09 - 3706 citationsGuidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Associa...Walter N. Kernan, Bruce Ovbiagele, Henry R. Black, Dawn M. Bravata, Marc I. Chimowitz
Stroke. 2011-01-01
Press Mentions
New Guideline: Preventing a First Stroke May Be Possible with Screening, Lifestyle ChangesOctober 21st, 2024- Primary Care of Adult Patients After Stroke A Scientific Statement from the American Heart Association/American Stroke AssociationJuly 20th, 2021
- AHA: Patients Should Visit PCP Within 3 Weeks of Stroke to Prevent RecurrenceJuly 15th, 2021
- Join now to see all
Grant Support
- Insulin Resistance Intervention After Stroke (IRIS) TrialNational Institute Of Neurological Disorders And Stroke2009–2011
- Insulin Resistance Inten/Ention After Stroke (IRIS) TrialNational Institute Of Neurological Disorders And Stroke2009–2011
- Insulin Resistance Intervention After Stroke TrialNational Institute Of Neurological Disorders And Stroke2004–2008
- Temporal Trend In Insulin Resistance After StrokesNational Center For Research Resources2004
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
